Stock MVF MONASH IVF GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Monash IVF Group Limited

Equities

MVF

AU000000MVF3

Healthcare Facilities & Services

Market Closed - Australian S.E.
Other stock markets
 02:10:11 2024-05-03 EDT 		5-day change 1st Jan Change
1.485 AUD +1.71% Intraday chart for Monash IVF Group Limited +2.77% +14.23%
04-30 Wilsons Upgrades Monash IVF to Overweight from Market-Weight, Price Target is AU$1.58 MT
04-12 RBC Capital Markets Starts Monash IVF Group at New Sector Perform, Price Target is AU$1.50 MT

Valuation

Fiscal Period: Juni 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 328.9 206.5 331.2 366.3 446.1 578.6 - -
Enterprise Value (EV) 1 413.6 210.7 324.1 368.4 477.1 620.3 609.8 599.3
P/E ratio - 11.8 x - 20 x 20.4 x 21.3 x 17.7 x 16.8 x
Yield 4.3% 3.96% 4.94% 4.68% 3.84% 3.37% 4% 4.33%
Capitalization / Revenue 2.16 x 1.42 x 1.8 x 1.9 x 2.09 x 2.28 x 2.11 x 2 x
EV / Revenue 2.72 x 1.45 x 1.77 x 1.92 x 2.23 x 2.44 x 2.23 x 2.07 x
EV / EBITDA 10.9 x 6.06 x 6.79 x 7.65 x 8.93 x 9.42 x 8.52 x 7.89 x
EV / FCF - 8.93 x - 22.1 x - 20.3 x 16.2 x 15.1 x
FCF Yield - 11.2% - 4.53% - 4.92% 6.19% 6.64%
Price to Book 1.9 x 0.54 x 1.24 x 1.37 x 1.63 x 2.08 x 2 x 1.91 x
Nbr of stocks (in thousands) 235,786 389,635 389,635 389,635 389,635 389,635 - -
Reference price 2 1.395 0.5300 0.8500 0.9400 1.145 1.485 1.485 1.485
Announcement Date 19-08-25 20-08-23 21-08-23 22-08-25 23-08-21 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 152 145.4 183.6 192.3 213.6 254.3 274 289.7
EBITDA 1 37.82 34.8 47.75 48.14 53.43 65.84 71.6 75.99
EBIT 1 32.74 24.45 34.86 33.36 38.09 46.09 51.23 54.42
Operating Margin 21.54% 16.81% 18.99% 17.35% 17.83% 18.13% 18.7% 18.78%
Earnings before Tax (EBT) 27.48 16.13 - 26.22 29.84 - 46.22 49.8
Net income 1 19.85 11.73 25.15 18.41 21.84 27.31 32.28 35.14
Net margin 13.06% 8.06% 13.7% 9.57% 10.22% 10.74% 11.78% 12.13%
EPS 2 - 0.0450 - 0.0470 0.0560 0.0698 0.0838 0.0882
Free Cash Flow 1 - 23.6 - 16.7 - 30.5 37.75 39.78
FCF margin - 16.23% - 8.68% - 12% 13.78% 13.73%
FCF Conversion (EBITDA) - 67.82% - 34.69% - 46.33% 52.73% 52.34%
FCF Conversion (Net income) - 201.26% - 90.73% - 111.66% 116.93% 113.19%
Dividend per Share 2 0.0600 0.0210 0.0420 0.0440 0.0440 0.0501 0.0594 0.0643
Announcement Date 19-08-25 20-08-23 21-08-23 22-08-25 23-08-21 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: Juni 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 77.05 68.37 90.78 92.83 101 91.32 103.3 110.3 125.7 128.3
EBITDA 1 16.8 17.98 24.72 23.03 26.77 21.38 26.8 26.63 32.16 34.6
EBIT 1 14.2 10.28 18.42 16.44 19.39 13.97 18.84 19.25 22.48 23.5
Operating Margin 18.43% 15.03% 20.29% 17.71% 19.2% 15.3% 18.24% 17.45% 17.88% 18.32%
Earnings before Tax (EBT) 11.05 - - - 17.13 9.091 14.76 15.08 17.74 -
Net income 1 8.157 3.569 14.56 10.59 12.08 6.321 10.64 11.16 12.77 14.6
Net margin 10.59% 5.22% 16.04% 11.41% 11.97% 6.92% 10.3% 10.12% 10.16% 11.38%
EPS 0.0350 - - - 0.0310 0.0160 0.0270 0.0290 0.0330 -
Dividend per Share 2 0.0210 - 0.0210 0.0210 0.0220 0.0220 0.0220 0.0220 0.0250 0.0250
Announcement Date 20-02-20 20-08-23 21-02-23 21-08-23 22-02-16 22-08-25 23-02-20 23-08-21 24-02-22 -
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: Juni 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 84.7 4.2 - 2.1 31 41.7 31.2 20.7
Net Cash position 1 - - 7.1 - - - - -
Leverage (Debt/EBITDA) 2.24 x 0.1207 x - 0.0436 x 0.5802 x 0.6337 x 0.4363 x 0.2722 x
Free Cash Flow 1 - 23.6 - 16.7 - 30.5 37.8 39.8
ROE (net income / shareholders' equity) 12% 5.7% 8.6% 8.2% 9.3% 11.1% 12.3% 12.7%
ROA (Net income/ Total Assets) 7.2% 4.1% 7.18% 5.03% 5.44% 7.23% 7.65% 7.82%
Assets 1 275.7 286 350.1 365.6 401.4 377.6 422.1 449.6
Book Value Per Share 2 0.7400 0.9800 0.6800 0.6900 0.7000 0.7100 0.7400 0.7800
Cash Flow per Share 2 0.1400 0.1200 0.1100 0.0800 0.1000 0.1300 0.1300 0.1400
Capex 1 6.54 7.5 11.3 11.8 27.8 21 15.4 16.3
Capex / Sales 4.3% 5.16% 6.15% 6.12% 13.01% 8.25% 5.62% 5.63%
Announcement Date 19-08-25 20-08-23 21-08-23 22-08-25 23-08-21 - - -
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Monash IVF Group Limited

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1.485 AUD
Average target price
1.541 AUD
Spread / Average Target
+3.76%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
MONASH IVF GROUP LIMITED Stock Monash IVF Group Limited
+14.23% 383M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.70% 81.4B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-29.20% 70.18B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+9.72% 29.08B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-11.43% 16.97B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.43% 16.96B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-0.31% 15.26B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+3.42% 12.41B
PURE HEALTH HOLDING Stock Pure Health Holding
-30.70% 11.95B
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
-6.75% 11.93B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. MVF Stock
  4. Financials Monash IVF Group Limited